Allogene Therapeutics, Inc.
METHODS AND REAGENTS FOR CHARACTERIZING CAR T CELLS FOR THERAPIES

Abstract:

Provided herein are methods, kits and reagents for analyzing attributes of engineered immune cells, such as CAR T cells. For example, provided herein are methods of determining the amount or percentage of residual TCR.alpha..beta.+ CAR T cells in allogeneic CAR T cell drug product and characterizing other important attributes of CAR T cell drug product.